Kazia Therapeutics (KZIA) Assets Average (2009 - 2025)

Kazia Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $25.3 million for Q4 2025.

• Quarterly Assets Average rose 94.97% year-over-year to $25.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.3 million (up 94.97% YoY) and the FY2025 annual result came in at $9.1 million, down 45.13% from the prior year.
• Assets Average was $25.3 million for Q4 2025 at Kazia Therapeutics, up from $7.8 million in the prior quarter.
• Across five years, Assets Average topped out at $38.6 million in Q4 2021 and bottomed at $7.8 million in Q2 2025.
• A 5-year average of $22.2 million and a median of $19.9 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average jumped 153.03% — and 2025, when it sank 48.19%.
• Kazia Therapeutics' Assets Average stood at $38.6 million in 2021, then slumped by 44.77% to $21.3 million in 2022, then fell by 18.82% to $17.3 million in 2023, then fell by 25.13% to $13.0 million in 2024, then surged by 94.97% to $25.3 million in 2025.
• Business Quant data shows KZIA's Assets Average at $25.3 million in Q4 2025, $7.8 million in Q2 2025, and $13.0 million in Q4 2024.